Research programme: antibacterial therapeutics - ProtAffin/Valneva
Alternative Names: Spy 0416Latest Information Update: 04 Sep 2013
At a glance
- Originator Intercell; ProtAffin Biotechnologie
- Developer ProtAffin Biotechnologie; Valneva
- Class Antigens; Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections